DD — DuPont de Nemours, Inc.

DuPont Q2 2026 Earnings Call Summary

1. Key Financial Results and Metrics

• Net Sales: $1.8 billion, up 4% year-over-year, driven by organic sales growth.
• Operating EBITDA: $448 million, an 8% increase from the previous year, with a margin of 24.6%, reflecting an 80 basis point year-over-year improvement.
• Adjusted EPS: $1.88, a 21% increase compared to the prior year.
• Free Cash Flow: $326 million, with a conversion rate of 127%, exceeding the target of 90%.
• Organic Sales Growth: 4% overall, with notable contributions from Healthcare, Water Technologies, and Diversified Industrials.

2. Strategic Updates and Business Highlights

• DuPont is focusing on operational excellence, innovation, and commercial discipline to drive sustainable performance.
• The company launched a $250 million share repurchase program and completed a reverse stock split to align performance metrics with industrial peers.
• Significant advancements in innovation were highlighted, including new products in lithium extraction and healthcare applications.
• The company is leveraging AI to enhance sales processes, achieving a 30% win rate on new opportunities, which is above historical benchmarks.

3. Forward Guidance and Outlook

• DuPont raised its full-year 2026 guidance for organic sales growth to slightly above 4%, with operating EBITDA expected to reach $1.76 billion.
• For Q3 2026, net sales are projected at $1.835 billion, with operating EBITDA of $448 million and adjusted EPS expected between $1.80 and $1.90.
• The company anticipates continued strength in healthcare, industrial water, and aerospace markets, with organic growth expectations of 6% year-over-year in the second half.

4. Bad News, Challenges, or Points of Concern

• The Water segment faced challenges due to geopolitical issues in the Middle East, impacting growth expectations and leading to a downward revision for the segment's full-year outlook.
• Margins in the Healthcare & Water Technologies segment contracted by 30 basis points, attributed to a less favorable product mix and growth investments.
• There are ongoing inflationary pressures from oil and gas, which are expected to impact margins in the second half of the year.

5. Notable Q&A Insights

• Innovation Contribution: The vitality index for innovation is at 35%, with a focus on maintaining a balance between growth and replacement products.
• Cost of Poor Quality: Currently at 4% of sales, below the benchmark of 5%, with plans to reduce this further through operational excellence initiatives.
• M&A Pipeline: DuPont has a robust M&A pipeline, particularly in the Water and Healthcare sectors, with over $1 billion available for acquisitions.
• Sales Strategy Changes: Compensation plans for the sales force are being revised to incentivize growth more effectively, transitioning to a commission-based structure in 2027.
• Market Dynamics: The company is optimistic about the EV battery market, projecting significant growth in this sector, which is currently a $70 million revenue stream.

Overall, DuPont's Q2 2026 results reflect a strong performance driven by strategic initiatives, although challenges remain in specific segments due to external factors. The company is well-positioned for continued growth with an optimistic outlook for the second half of the year.